Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Express Scripts
McKesson
Fuji
Cantor Fitzgerald
Moodys
Chinese Patent Office
Merck
Chubb
Healthtrust

Generated: February 21, 2018

DrugPatentWatch Database Preview

Actavis Llc Company Profile

« Back to Dashboard

What is the competitive landscape for ACTAVIS LLC, and what generic and branded alternatives to ACTAVIS LLC drugs are available?

ACTAVIS LLC has nine approved drugs.

There is one tentative approval on ACTAVIS LLC drugs.

Summary for Actavis Llc
US Patents:0
Tradenames:8
Ingredients:8
NDAs:9

Drugs and US Patents for Actavis Llc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Llc DOCETAXEL docetaxel INJECTABLE;INJECTION 203551-003 Apr 12, 2013 RX No No ➤ Sign Up ➤ Sign Up
Actavis Llc DOCETAXEL docetaxel INJECTABLE;INJECTION 203551-002 Apr 12, 2013 AP RX No No ➤ Sign Up ➤ Sign Up
Actavis Llc HYDROXOCOBALAMIN hydroxocobalamin INJECTABLE;INJECTION 085998-001 Approved Prior to Jan 1, 1982 RX No Yes ➤ Sign Up ➤ Sign Up
Actavis Llc MELPHALAN HYDROCHLORIDE melphalan hydrochloride INJECTABLE;INJECTION 206018-001 Dec 19, 2016 AP RX No No ➤ Sign Up ➤ Sign Up
Actavis Llc DOCETAXEL docetaxel INJECTABLE;INJECTION 203551-001 Apr 12, 2013 AP RX No No ➤ Sign Up ➤ Sign Up
Actavis Llc FLUDARABINE PHOSPHATE fludarabine phosphate INJECTABLE;INJECTION 203738-001 Feb 28, 2017 AP RX No No ➤ Sign Up ➤ Sign Up
Actavis Llc AZACITIDINE azacitidine POWDER;IV (INFUSION), SUBCUTANEOUS 208216-001 Apr 29, 2016 AP RX No No ➤ Sign Up ➤ Sign Up
Actavis Llc LEVOLEUCOVORIN CALCIUM levoleucovorin calcium POWDER;IV (INFUSION) 208723-001 Sep 29, 2016 RX Yes Yes ➤ Sign Up ➤ Sign Up
Actavis Llc DAPSONE dapsone TABLET;ORAL 204380-001 Mar 23, 2017 AB RX No No ➤ Sign Up ➤ Sign Up
Actavis Llc LEVOLEUCOVORIN CALCIUM levoleucovorin calcium POWDER;IV (INFUSION) 206516-001 Feb 13, 2017 AP RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Argus Health
Chinese Patent Office
Cerilliant
McKesson
Mallinckrodt
Teva
Moodys
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot